KPV Dosage Guide
Complete guide to KPV dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
200 mcg – 500 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
4–8 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Oral/sublingual
200-500mcg 1-3 times daily.
Topical formulations for localized inflammation.
Also used in enemas for gut inflammation.
Administration Method
Can be taken orally, sublingually, or as suppositories/enemas for gut inflammation. Topical use for skin conditions. Stable orally unlike most peptides.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.140 ml
Syringe units: 14.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with KPV defaults. Adjust values as needed.
Side Effects to Monitor
Generally very well-tolerated. Minimal systemic effects due to targeted anti-inflammatory action.
Safety Considerations & Risks
Limited clinical research. Mostly used based on extrapolation from α-MSH research. Long-term effects not characterized.